Search alternatives:
significantly related » significantly correlated (Expand Search), significantly elevated (Expand Search), significantly reduced (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
related decrease » reported decrease (Expand Search), related disease (Expand Search), greater decrease (Expand Search)
significantly related » significantly correlated (Expand Search), significantly elevated (Expand Search), significantly reduced (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
related decrease » reported decrease (Expand Search), related disease (Expand Search), greater decrease (Expand Search)
-
1641
-
1642
-
1643
-
1644
-
1645
-
1646
-
1647
-
1648
-
1649
Study Data.
Published 2025“…The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …”
-
1650
Study outcomes.
Published 2025“…The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …”
-
1651
Patient characteristics.
Published 2025“…The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …”
-
1652
-
1653
-
1654
-
1655
-
1656
Factors associated with anemia stratified by age group: By logistic regression.
Published 2025Subjects: -
1657
Factors associated with the hemoglobin level stratified by age group: Linear regression.
Published 2025Subjects: -
1658
The TOR inhibitors Rapamycin and AZD-8055 strongly reduce RPS6 phosphorylation and cell proliferation in Vasa2+/Piwi1+ cells.
Published 2025“…<b>(C, D)</b> Intensity measures of pRPS6 bands relative to the Actin control protein show that Rapamycin (C) and AZD-8055 (D) led to a decrease of phosphorylated RPS6 levels. …”
-
1659
Bromatological composition of fermented and dried cocoa beans at two fermentation times.
Published 2024Subjects: -
1660
Original data (a, b, c, d) and disproportionality analysis results (ROR & IC).
Published 2025Subjects: